The Foundation for Innovative New Diagnostics (FIND) is leading a consortium, of which Mologic is part, announced today the launch of a new schistosomiasis programme within its neglected tropical diseases (NTD) portfolio.
The programme focuses on developing rapid diagnostic tests (RDTs) for detection of circulating anodic antigen (CAA) in blood and/or urine, to support national control and/or elimination programmes in countries where schistosomiasis is regularly found.
Read more on the official website: www.finddx.org/news/find-extends-neglected-tropical-diseases-portfolio-to-include-schistosomiasis/
Leave A Comment